Subtopic Deep Dive
Deep Brain Stimulation Epilepsy
Research Guide
What is Deep Brain Stimulation Epilepsy?
Deep Brain Stimulation (DBS) for epilepsy involves implanting electrodes in the anterior nucleus of the thalamus or centromedian nucleus to deliver electrical pulses that reduce seizure frequency in drug-resistant focal epilepsy patients.
Clinical trials demonstrate anterior thalamic DBS achieves 69% median seizure reduction over 5 years (Salanova et al., 2015, 788 citations). Responsive neurostimulation provides long-term seizure control in refractory partial seizures over 5.4 years (Bergey et al., 2015, 618 citations). Early pilot studies confirmed efficacy of anterior thalamic stimulation in intractable epilepsy (Kerrigan et al., 2004, 480 citations).
Why It Matters
Anterior thalamic DBS offers a vital alternative for 30% of epilepsy patients unresponsive to medications, reducing seizures by 69% and improving quality of life (Salanova et al., 2015). Responsive brain stimulation targets focal epilepsy with personalized closed-loop delivery, achieving sustained efficacy over years (Bergey et al., 2015). These therapies address unmet needs in drug-resistant cases, with over 1,800 patients treated via FDA-approved devices like the RNS System.
Key Research Challenges
Optimizing Stimulation Parameters
Selecting pulse width, frequency, and amplitude for maximal seizure reduction remains trial-and-error based. Salanova et al. (2015) reported 34% serious device-related adverse events partly due to suboptimal programming. Long-term parameter adjustments are needed for sustained 69% efficacy.
Identifying Optimal Targets
Choosing between anterior thalamus, centromedian nucleus, or other sites lacks precise biomarkers. Kerrigan et al. (2004) piloted anterior thalamic stimulation but noted variable responses. Network-based targeting via resting-state connectivity shows promise but requires validation (Fox et al., 2014).
Managing Long-term Side Effects
Adverse events like infection and cognitive changes persist at 34% rate over 5 years (Salanova et al., 2015). Responsive stimulation reduces seizures but demands chronic implantation monitoring (Bergey et al., 2015). Predictive models for complications are absent.
Essential Papers
Triangulating a Cognitive Control Network Using Diffusion-Weighted Magnetic Resonance Imaging (MRI) and Functional MRI
Adam R. Aron, Timothy E.J. Behrens, Stephen M. Smith et al. · 2007 · Journal of Neuroscience · 988 citations
The ability to stop motor responses depends critically on the right inferior frontal cortex (IFC) and also engages a midbrain region consistent with the subthalamic nucleus (STN). Here we used diff...
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
Vicenta Salanova, Thomas J. Witt, Robert M. Worth et al. · 2015 · Neurology · 788 citations
This long-term follow-up provides Class IV evidence that for patients with drug-resistant partial epilepsy, anterior thalamic stimulation is associated with a 69% reduction in seizure frequency and...
Long-term treatment with responsive brain stimulation in adults with refractory partial seizures
Gregory K. Bergey, Martha J. Morrell, Eli M. Mizrahi et al. · 2015 · Neurology · 618 citations
This study provides Class IV evidence that for adults with medically refractory partial onset seizures, responsive direct cortical stimulation reduces seizures and improves quality of life over a m...
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Paul E. Holtzheimer · 2012 · Archives of General Psychiatry · 600 citations
The findings of this study support the long-term safety and antidepressant efficacy of subcallosal cingulate DBS for TRD and suggest equivalent safety and efficacy for TRD in patients with BP. Tria...
Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases
Michael Fox, Randy L. Buckner, Hesheng Liu et al. · 2014 · Proceedings of the National Academy of Sciences · 600 citations
Significance Brain stimulation is a powerful treatment for an increasing number of psychiatric and neurological diseases, but it is unclear why certain stimulation sites work or where in the brain ...
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Roumen Milev, Peter Giacobbe, Sidney H. Kennedy et al. · 2016 · The Canadian Journal of Psychiatry · 565 citations
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines ...
Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh Nouri Emamzadeh, Andrei Surguchov · 2018 · Frontiers in Neuroscience · 561 citations
Parkinson's disease (PD) is a progressive neurodegenerative disorder caused mainly by lack of dopamine in the brain. Dopamine is a neurotransmitter involved in movement, motivation, memory, and oth...
Reading Guide
Foundational Papers
Start with Kerrigan et al. (2004, 480 citations) for anterior thalamic pilot establishing feasibility, then Salanova et al. (2015, 788 citations) for 5-year Class IV evidence of 69% reduction.
Recent Advances
Study Bergey et al. (2015, 618 citations) for responsive stimulation long-term data and Fox et al. (2014, 600 citations) for network targeting applicable to epilepsy DBS.
Core Methods
Core techniques: intermittent thalamic stimulation (Kerrigan et al., 2004), responsive cortical detection (Bergey et al., 2015), resting-state network mapping (Fox et al., 2014).
How PapersFlow Helps You Research Deep Brain Stimulation Epilepsy
Discover & Search
Research Agent uses searchPapers('anterior thalamic DBS epilepsy') to retrieve Salanova et al. (2015, 788 citations), then citationGraph to map citing works on long-term outcomes and findSimilarPapers for responsive stimulation parallels like Bergey et al. (2015). exaSearch uncovers closed-loop paradigms in focal epilepsy.
Analyze & Verify
Analysis Agent applies readPaperContent on Salanova et al. (2015) to extract 69% seizure reduction stats, verifyResponse with CoVe against raw trial data, and runPythonAnalysis for survival curve meta-analysis across trials. GRADE grading assesses Class IV evidence quality for thalamic stimulation.
Synthesize & Write
Synthesis Agent detects gaps in closed-loop targeting via contradiction flagging between Kerrigan et al. (2004) pilot and Salanova et al. (2015) long-term data; Writing Agent uses latexEditText for methods sections, latexSyncCitations for 788-citation integration, and latexCompile for review manuscripts. exportMermaid visualizes thalamic network diagrams.
Use Cases
"Plot seizure frequency reduction curves from DBS epilepsy trials"
Research Agent → searchPapers('DBS epilepsy trials') → Analysis Agent → runPythonAnalysis(pandas plot of Salanova 2015 and Bergey 2015 Kaplan-Meier data) → matplotlib survival graphs with 69% and 5.4-year metrics.
"Draft LaTeX review on anterior thalamic DBS outcomes"
Synthesis Agent → gap detection (parameter optimization gaps) → Writing Agent → latexEditText(structure review) → latexSyncCitations(Salanova 2015, Kerrigan 2004) → latexCompile → PDF with embedded tables.
"Find code for epilepsy seizure detection in DBS papers"
Research Agent → searchPapers('responsive neurostimulation epilepsy code') → Code Discovery → paperExtractUrls(Bergey 2015) → paperFindGithubRepo → githubRepoInspect → Python scripts for ECoG signal processing.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ DBS epilepsy papers) → citationGraph → GRADE grading → structured report on 69% reduction meta-analysis. DeepScan applies 7-step analysis with CoVe checkpoints on Salanova et al. (2015) for adverse event verification. Theorizer generates hypotheses on network targets linking Fox et al. (2014) resting-state data to thalamic stimulation.
Frequently Asked Questions
What is Deep Brain Stimulation for epilepsy?
DBS implants electrodes in the anterior thalamus to deliver electrical pulses reducing seizures in drug-resistant focal epilepsy by 69% median over 5 years (Salanova et al., 2015).
What are main methods in DBS epilepsy research?
Anterior thalamic stimulation (Kerrigan et al., 2004) and responsive neurostimulation (Bergey et al., 2015) use chronic electrical delivery; closed-loop paradigms detect and respond to seizure activity.
What are key papers on DBS for epilepsy?
Salanova et al. (2015, 788 citations) shows 69% seizure reduction; Bergey et al. (2015, 618 citations) validates responsive stimulation over 5.4 years; Kerrigan et al. (2004, 480 citations) provides pilot evidence.
What are open problems in DBS epilepsy?
Challenges include parameter optimization, target selection beyond anterior thalamus, and reducing 34% adverse event rates (Salanova et al., 2015); closed-loop biomarkers remain underdeveloped.
Research Neurological disorders and treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Deep Brain Stimulation Epilepsy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers